Noam Asna

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 123 citations · Full text

The Role of Nurses in the Quality of Cancer Care Management: Perceptions of Cancer Survivors and Oncology Teams

Osnat Bashkin, Noam Asna, Mazal Amoyal et al. · Seminars in Oncology Nursing · 2023 · 41 citations

Nursing, Cancer Care Management, Medicine +9

Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity

Noam Asna, H. Lewy, Israel Ashkenazi et al. · Life Sciences · 2005 · 33 citations

Biochemistry, Medicine, Toxicology +8

Facing the Unknown: Healthcare Workers’ Concerns, Experiences, and Burnout during the COVID-19 Pandemic—A Mixed-Methods Study in an Israeli Hospital

Keren Dopelt, Osnat Bashkin, Nadav Davidovitch et al. · Sustainability · 2021 · 25 citations · Full text

Mental Resilience, Worker Health, Covid-19 +19

Assessing the effectiveness of Dead Sea products as prophylactic agents for acute radiochemotherapy-induced skin and mucosal toxicity in patients with head and neck cancers: a phase 2 study.

Diana Matceyevsky, Neora Yaal Hahoshen, Akiva Vexler et al. · PubMed · 2007 · 17 citations